HLA as a marker gene in the diagnosis and treatment of chronic rheumatoid arthritis
Nishimura, Y.; Sasatsuki, T.
Ryumachi 28(6): 463-466
1988
ISSN/ISBN: 0300-9157 PMID: 3249992 Document Number: 309115
Document emailed within 1 workday
Related Documents
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Swaak, A. 2006: Anemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity Journal of Rheumatology 33(8): 1467-1468
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Kudo, Y. 1972: Treatment of chronic rheumatoid arthritis--prognosis and complications Nursing Technique 18(11): 37-47
Mowat, A.G. 1983: Rheumatoid arthritis. Presentation, diagnosis and treatment Practitioner 227(1381): 1103-1117
Sherry, D.D. 2000: What's new in the diagnosis and treatment of juvenile rheumatoid arthritis Journal of Pediatric Orthopedics 20(4): 419-420
Gupta, A.K.; Cernea, M.; Lynde, C.W. 2017: Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis Skin Therapy Letter 22(2): 1-7
Shiokawa, Y.; Abe, T.; Onoda, T. 1974: Evaluation of 19583RP (ketoprofen) in the treatment of chronic rheumatoid arthritis Ryumachi 14(3): 279-286
Komarova, O.B.; Rebrov, B.O.; Libster, K.S.; Pankrat'iev, O.O. 2013: Possibilities of arthroscopy in the diagnosis and treatment of rheumatoid arthritis Likars'ka Sprava 8: 79-84
Schipper, L.G.; Hoekstra, M.; Vliet Vlieland, T.P.M.; Jansen, T.L.; Lems, W.F.; van Riel, P..L.C.M. 2009: Practice guideline 'Diagnosis and treatment of rheumatoid arthritis' Nederlands Tijdschrift Voor Geneeskunde 153: A944
Abu Al Fadl, E.M.; Fattouh, M.; Allam, A.A. 2013: High IL-23 level is a marker of disease activity in rheumatoid arthritis Egyptian Journal of Immunology 20(2): 85-92
Basu, P.S.; Majhi, R.; Ghosal, S.; Batabyal, S.K. 2011: Peptidyl-Arginine Deiminase: An Additional Marker of Rheumatoid Arthritis Clinical Laboratory 57(11-12): 1021-1025
Haberhauer, G.; Kittl, E.M. 1998: Soluble CD44 isoform variant-5 (sCD44v5): a new serum marker in rheumatoid arthritis? Journal of Rheumatology 25(7): 1442-1444
Syed Mohamed Suhail, S.M.; Nur Atiqah, I.; Nur Salimi Zakirah, Z.A.; Lailatul Syazwani, Z.; Batis, W.W.; Md Monoto, E.M.; Abdul Wahab, A.; Mohd Shahrir, M.S. 2019: Diagnostic performance of anti-RA33 antibody as a serological marker for rheumatoid arthritis Malaysian Journal of Pathology 41(3): 259-265
Hayem, G.; Chazerain, P.; Combe, B.; Elias, A.; Haim, T.; Nicaise, P.; Benali, K.; Eliaou, J.F.; Kahn, M.F.; Sany, J.; Meyer, O. 1999: Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis Journal of Rheumatology 26(1): 7-13
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571